Carrier Route Information System (CRIS)

Type: Public
On the web: http://www.curis.com
Employees: 32
Employee growth: (3.0%)

Curis's cancer patients and Sega's gamers might one day have an unlikely hero in common: Sonic the Hedgehog. Drug development firm Curis is studying hedgehog signaling pathways (including the sonic hedgehog pathway, named after the Sega mascot) to find treatments for oncology ailments and other conditions. Such signaling pathways regulate tissue growth and repair, and the company is looking for ways to either stimulate them or slow them down as a means of treating disease. Curis is collaborating with Genentech to develop cancer drugs using hedgehog pathways. The company also has internal development programs for cancer treatments using other signaling pathways.

Key numbers for fiscal year ending December, 2010:
Sales: $16.0M
One year growth: 86.3%
Net income: ($4.4)M

Officers:
Chairman: James R. McNab Jr.
President, CEO, and Director: Daniel R. (Dan) Passeri
CFO, COO and Secretary: Michael P. (Mike) Gray

Competitors:
Exelixis
Infinity Pharmaceuticals
Pfizer

Click to Play

Devil May Cry 4 - Secret Missions Walkthroughs

Click to Play

DMC: Devil May Cry Announcement Trailer

Click to Play

Why We Cry When We Are Sad

Click to Play

Facts About Crying Babies

View more Business & Finance videos

File maintained by the U.S. Postal Service that lists all of the approximately 570,000 carrier routes by street name or ranges of street numbers. It is used by large-volume mailers to append the carrier route to the name and address records on their mailing lists so that mailings can be presorted accordingly, thereby earning a postage discount. See also address coding guide; carrier route coding; carrier route presort; carrier route qualified.